Retour
32
Fourchette du Jour
24,20 €
26,30 €
Fourchette 52 Semaines
24,20 €
34,00 €
Volume
1 100
Moyenne 50J / 200J
26,72 €
/
29,11 €
Clôture Précédente
24,20 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 43,3 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | 5,9 | 3,7 |
| Net Margin % | 9,6 | 3,8 |
| Rev Growth 5Y % | 28,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Revenue grew 28,44% annually over 5 years — strong growth
Earnings grew 68,02% over the past year
Debt/Equity of 0,09 — conservative balance sheet
Generating 59,41M in free cash flow
P/E of 43,27 — premium valuation
PEG of 0,82 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
28,44%
Revenue (1Y)8,66%
Earnings (1Y)68,02%
FCF Growth (3Y)-14,45%
Qualité
Return on Equity
5,90%
ROIC5,13%
Net Margin9,56%
Op. Margin12,28%
Sécurité
Debt / Equity
0,09
Current Ratio0,66
Interest Coverage8,75
Valorisation
P/E Ratio
43,27
P/B Ratio2,52
EV/EBITDA32,73
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,66% | Revenue Growth (3Y) | 8,71% |
| Earnings Growth (1Y) | 68,02% | Earnings Growth (3Y) | 45,94% |
| Revenue Growth (5Y) | 28,44% | Earnings Growth (5Y) | 11,10% |
| Profitability | |||
| Revenue (TTM) | 205,66M | Net Income (TTM) | 19,66M |
| ROE | 5,90% | ROA | 3,57% |
| Gross Margin | 87,17% | Operating Margin | 12,28% |
| Net Margin | 9,56% | Free Cash Flow (TTM) | 59,41M |
| ROIC | 5,13% | FCF Growth (3Y) | -14,45% |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 0,66 |
| Interest Coverage | 8,75 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 43,27 | P/B Ratio | 2,52 |
| P/S Ratio | 4,14 | PEG Ratio | 0,82 |
| EV/EBITDA | 32,73 | Dividend Yield | 0,01% |
| Market Cap | 850,72M | Enterprise Value | 826,46M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 205,66M | 189,27M | 174,02M | 165,54M | 75,58M |
| Net Income | 19,66M | 11,70M | 9,23M | 9,41M | 12,91M |
| EPS (Diluted) | 0,55 | 0,33 | 0,26 | 0,27 | 0,48 |
| Gross Profit | 179,27M | 162,20M | 122,71M | 103,44M | 66,71M |
| Operating Income | 25,25M | 19,73M | 19,23M | 18,13M | 13,24M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 551,06M | 543,66M | 583,33M | 574,64M | 311,88M |
| Total Liabilities | 213,50M | 215,06M | 256,02M | 240,89M | 51,60M |
| Shareholders' Equity | 337,56M | 328,59M | 327,31M | 333,75M | 260,28M |
| Total Debt | 31,65M | 40,15M | 86,55M | 115,78M | 2,20M |
| Cash & Equivalents | 55,92M | 34,59M | 78,41M | 48,51M | 235,62M |
| Current Assets | 119,59M | 93,23M | 113,96M | 87,99M | 253,60M |
| Current Liabilities | 181,11M | 148,76M | 127,38M | 78,08M | 49,41M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#773 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026